# Hideo Koyama

> Hideo Koyama is a startup investor at CellSource. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [CellSource](https://shizune.co/investors/profile/cellsource)
- Last updated: Aug 2026

Hideo Koyama is a startup investor at CellSource. Hideo Koyama

## About CellSource

VC Fund · Tokyo, Japan

CellSource provides adipose-derived stem cell processing services, blood-derived processing contract services, and support services for compliance with laws and regulations in areas such as regenerative medicine.

5 contacts available at CellSource.

| Name | Title | Profile |
| --- | --- | --- |
| Hideo Koyama | Auditor | https://shizune.co/investors/profile/hideo-koyama |
| Hirohiko Hanaki | Director, Chief Compliance Officer (CCO) & Head of Regenerative Medicine Business Division | https://shizune.co/investors/profile/hirohiko-hanaki |
| Kaneshima Hideto | Chief Technical Advisor & Doctor of Medicine | https://shizune.co/investors/profile/kaneshima-hideto |
| Kenta Fujita | Executive Officer | https://shizune.co/investors/profile/kenta-fujita |
| Masahiro Samejima | General Counsel and Patent Attorney | https://shizune.co/investors/profile/masahiro-samejima |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co